Drugs / Sevofluorane
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07123870 | Jul → Oct 2025 overdue | — | Kocaeli City Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT02110745 | Mar → Nov 2014 | cryptorchidism | Mustafa Kemal University | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sevofluorane | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02110745 ↗ |
| Route | Inhaled | “sevofluorane (increasing concentrations up to 8%) administered by mask” NCT02110745 ↗ |